[ad_1] SCHAUMBURG, Ill., Nov. 26, 2025 /PRNewswire/ — Cure SMA, the leading nonprofit organization dedicated to supporting those impacted by spinal muscular atrophy (SMA), welcomes the FDA approval of Itvisma™ (onasemnogene abeparvovec-brve) by Novartis for […]
